GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Free cash flow, FY2025
- £6.4B
- YoY, FY2025
- +24.0%
- 5-year CAGR
- −3.0%
- 10-year CAGR
- +18.3%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| FY2025 | £6.4B | +24.0% |
| FY2024 | £5.2B | −5.5% |
| FY2023 | £5.5B | −12.9% |
| FY2022 | £6.3B | −10.6% |
| FY2021 | £7.0B | −6.0% |
| FY2020 | £7.5B | +10.3% |
| FY2019 | £6.8B | −4.5% |
| FY2018 | £7.1B | +31.7% |
| FY2017 | £5.4B | +8.5% |
| FY2016 | £5.0B | +316.7% |
| FY2015 | £1.2B | — |